Studies using immunostaining demonstrate that in AD, the MAO-B level is significantly increased in the hippocampus and in the cortical areas, whereas MAO-A activity is enhanced in the frontal pole and hypothalamus [80]. This evidence concerns the gene MAOB and Alzheimer disease.